{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:47:23Z","timestamp":1792291643924,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/leu.2009.134","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T05:40:05Z","timestamp":1247118005000},"page":"1691-1697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":202,"title":["Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic\/racial groups: support for genetic factors in pathogenesis"],"prefix":"10.1038","volume":"23","author":[{"given":"O","family":"Landgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"BFleu2009134_CR1","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV . Multiple myeloma. N Engl J Med 2004; 351: 1860\u20131873.","journal-title":"N Engl J Med"},{"key":"BFleu2009134_CR2","unstructured":"Anonymous. Cancer facts & figures 2008. American Cancer Society: Atlanta, 2008."},{"key":"BFleu2009134_CR3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 1362\u20131369.","journal-title":"N Engl J Med"},{"key":"BFleu2009134_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Kyle RA, Therneau TM, Melton III LJ, Bradwell AR, Clark RJ et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005; 106: 812\u2013817.","journal-title":"Blood"},{"key":"BFleu2009134_CR5","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB et al. Monoclonal gammopathy of undetermined significance (MGUS) preceding multiple myeloma: a prospective study. Blood 2009; 113: 5412\u20135417.","journal-title":"Blood"},{"key":"BFleu2009134_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4065\/82.4.428","volume":"82","author":"L Rosinol","year":"2007","unstructured":"Rosinol L, Cibeira MT, Montoto S, Rozman M, Esteve J, Filella X et al. Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size. Mayo Clin Proc 2007; 82: 428\u2013434.","journal-title":"Mayo Clin Proc"},{"key":"BFleu2009134_CR7","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM . A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 2009; 113: 5418\u20135422.","journal-title":"Blood"},{"key":"BFleu2009134_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1023\/A:1022268103136","volume":"22","author":"M Benjamin","year":"2003","unstructured":"Benjamin M, Reddy S, Brawley OW . Myeloma and race: a review of the literature. Cancer Metastasis Rev 2003; 22: 87\u201393.","journal-title":"Cancer Metastasis Rev"},{"key":"BFleu2009134_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","volume":"107","author":"O Landgren","year":"2006","unstructured":"Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006; 107: 904\u2013906.","journal-title":"Blood"},{"key":"BFleu2009134_CR10","first-page":"211","volume":"56","author":"J Waldenstrom","year":"1960","unstructured":"Waldenstrom J . Studies on conditions associated with disturbed gamma globulin formation (gammopathies). Harvey Lect 1960; 56: 211\u2013231.","journal-title":"Harvey Lect"},{"key":"BFleu2009134_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1978","unstructured":"Kyle RA . Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 1978; 64: 814\u2013826.","journal-title":"Am J Med"},{"key":"BFleu2009134_CR12","first-page":"2832","volume":"354","author":"HJ Cohen","year":"2006","unstructured":"Cohen HJ . Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006; 354: 2832; author reply 2832.","journal-title":"N Engl J Med"},{"key":"BFleu2009134_CR13","first-page":"785","volume":"116","author":"J Singh","year":"1990","unstructured":"Singh J, Dudley Jr AW, Kulig KA . Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting. J Lab Clin Med 1990; 116: 785\u2013789.","journal-title":"J Lab Clin Med"},{"key":"BFleu2009134_CR14","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","volume":"82","author":"O Landgren","year":"2007","unstructured":"Landgren O, Katzmann JA, Hsing AW, Pfeiffer RM, Kyle RA, Yeboah ED et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007; 82: 1468\u20131473.","journal-title":"Mayo Clin Proc"},{"key":"BFleu2009134_CR15","unstructured":"Anonymous. World Factbook of CIA. 2006 [cited 2009 April 29]; Available from: http:\/\/www.umsl.edu\/services\/govdocs\/wofact2006\/geos\/mb.html#Intro."},{"key":"BFleu2009134_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/sj.leu.2402040","volume":"15","author":"C Besson","year":"2001","unstructured":"Besson C, Gonin C, Brebion A, Delaunay C, Panelatti G, Plumelle Y . Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia\/lymphoma. Leukemia 2001; 15: 828\u2013831.","journal-title":"Leukemia"},{"key":"BFleu2009134_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1532-5415.1993.tb05940.x","volume":"41","author":"M Bowden","year":"1993","unstructured":"Bowden M, Crawford J, Cohen HJ, Noyama O . A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly. J Am Geriatr Soc 1993; 41: 11\u201314.","journal-title":"J Am Geriatr Soc"},{"key":"BFleu2009134_CR18","volume-title":"Cancer Incidence in Five Continents","author":"DM Parkin","year":"2002","unstructured":"Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB . Cancer Incidence in Five Continents, Vol VIII International Agency for Research on Cancer: Lyon, France, 2002."},{"key":"BFleu2009134_CR19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","volume":"82","author":"M Iwanaga","year":"2007","unstructured":"Iwanaga M, Tagawa M, Tsukasaki K, Kamihira S, Tomonaga M . Prevalence of monoclonal gammopathy of undetermined significance: study of 52\u2009802 persons in Nagasaki City, Japan. Mayo Clin Proc 2007; 82: 1474\u20131479.","journal-title":"Mayo Clin Proc"},{"key":"BFleu2009134_CR20","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1182\/blood-2008-05-159665","volume":"113","author":"M Iwanaga","year":"2009","unstructured":"Iwanaga M, Tagawa M, Tsukasaki K, Matsuo T, Yokota K, Miyazaki Y et al. Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors. Blood 2009; 113: 1639\u20131650.","journal-title":"Blood"},{"key":"BFleu2009134_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1148\/5.2.132","volume":"5","author":"HW Meyerding","year":"1925","unstructured":"Meyerding HW . Multiple myeloma. Radiology 1925; 5: 132\u2013136.","journal-title":"Radiology"},{"key":"BFleu2009134_CR22","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/1097-0142(19851015)56:8<2133::AID-CNCR2820560842>3.0.CO;2-F","volume":"56","author":"CC Bourguet","year":"1985","unstructured":"Bourguet CC, Grufferman S, Delzell E, DeLong ER, Cohen HJ . Multiple myeloma and family history of cancer. A case\u2013control study. Cancer 1985; 56: 2133\u20132139.","journal-title":"Cancer"},{"key":"BFleu2009134_CR23","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2385::AID-CNCR13>3.0.CO;2-A","volume":"85","author":"LM Brown","year":"1999","unstructured":"Brown LM, Linet MS, Greenberg RS, Silverman DT, Hayes RB, Swanson GM et al. Multiple myeloma and family history of cancer among blacks and whites in the US. Cancer 1999; 85: 2385\u20132390.","journal-title":"Cancer"},{"key":"BFleu2009134_CR24","first-page":"2378","volume":"54","author":"LA Cannon-Albright","year":"1994","unstructured":"Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M et al. Familiality of cancer in Utah. Cancer Res 1994; 54: 2378\u20132385.","journal-title":"Cancer Res"},{"key":"BFleu2009134_CR25","first-page":"66","volume":"90","author":"HM Ogmundsdottir","year":"2005","unstructured":"Ogmundsdottir HM, Haraldsdottirm V, Johannesson GM, Olafsdottir G, Bjarnadottir K, Sigvaldason H et al. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families. Haematologica 2005; 90: 66\u201371.","journal-title":"Haematologica"},{"key":"BFleu2009134_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00051914","volume":"3","author":"M Eriksson","year":"1992","unstructured":"Eriksson M, Hallberg B . Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case\u2013control study. Cancer Causes Control 1992; 3: 63\u201367.","journal-title":"Cancer Causes Control"},{"key":"BFleu2009134_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/jnci\/94.6.462","volume":"94","author":"K Hemminki","year":"2002","unstructured":"Hemminki K . Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 2002; 94: 462\u2013463; author reply 463.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2009134_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/(SICI)1098-2272(1998)15:3<225::AID-GEPI2>3.0.CO;2-3","volume":"15","author":"K Hemminki","year":"1998","unstructured":"Hemminki K, Vaittinen P . National database of familial cancer in Sweden. Genet Epidemiol 1998; 15: 225\u2013236.","journal-title":"Genet Epidemiol"},{"key":"BFleu2009134_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1200\/JCO.2005.10.126","volume":"23","author":"HT Lynch","year":"2005","unstructured":"Lynch HT, Watson P, Tarantolo S, Wiernik PH, Quinn-Laquer B, Isgur Bergsagel K et al. Phenotypic heterogeneity in multiple myeloma families. J Clin Oncol 2005; 23: 685\u2013693.","journal-title":"J Clin Oncol"},{"key":"BFleu2009134_CR30","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/jnci\/93.19.1479","volume":"93","author":"HT Lynch","year":"2001","unstructured":"Lynch HT, Sanger WG, Pirruccello S, Quinn-Laquer B, Weisenburger DD . Familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 2001; 93: 1479\u20131483.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2009134_CR31","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1002\/ijc.21745","volume":"118","author":"O Landgren","year":"2006","unstructured":"Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR . Familial characteristics of autoimmune and hematologic disorders in 8406 multiple myeloma patients: a population-based case\u2013control study. Int J Cancer 2006; 118: 3095\u20133098.","journal-title":"Int J Cancer"},{"key":"BFleu2009134_CR32","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1158\/1055-9965.EPI-04-0783","volume":"14","author":"SE Daugherty","year":"2005","unstructured":"Daugherty SE, Pfeiffer RM, Mellemkjaer L, Hemminki K, Goldin LR . No evidence for anticipation in lymphoproliferative tumors in population-based samples. Cancer Epidemiol Biomarkers Prev 2005; 14: 1245\u20131250.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFleu2009134_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1056\/NEJMoa0708704","volume":"359","author":"HT Lynch","year":"2008","unstructured":"Lynch HT, Ferrara K, Barlogie B, Coleman EA, Lynch JF, Weisenburger D et al. Familial myeloma. N Engl J Med 2008; 359: 152\u2013157.","journal-title":"N Engl J Med"},{"key":"BFleu2009134_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ajh.21325","volume":"84","author":"M Jain","year":"2009","unstructured":"Jain M, Ascensao J, Schechter GP . Familial myeloma and monoclonal gammopathy: a report of eight African American families. Am J Hematol 2009; 84: 34\u201338.","journal-title":"Am J Hematol"},{"key":"BFleu2009134_CR35","doi-asserted-by":"crossref","unstructured":"Landgren O, Kristinsson SY, Goldin LR, Caporaso NE, Blimark C, Mellqvist UH et al. Risk of plasma-cell and lymphoproliferative disorders among 14\u2009621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance (MGUS) in Sweden. Blood 2009, January 30 [E-pub ahead of print].","DOI":"10.1182\/blood-2008-12-191676"},{"key":"BFleu2009134_CR36","doi-asserted-by":"crossref","unstructured":"Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL et al. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood 2009, January 29 [E-pub ahead of print].","DOI":"10.1182\/blood-2008-12-192575"},{"key":"BFleu2009134_CR37","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMc081677","volume":"359","author":"NJ Camp","year":"2008","unstructured":"Camp NJ, Werner TL, Cannon-Albright LA . Familial myeloma. N Engl J Med 2008; 359: 1734\u20131735; author reply 1735.","journal-title":"N Engl J Med"},{"key":"BFleu2009134_CR38","doi-asserted-by":"crossref","unstructured":"Kristinsson SY, Goldin LR, Bjorkholm M, Turesson I, Landgren O . Risk of solid tumors and myeloid hematologic malignancies among first-degree relatives of monoclonal gammopathy of undetermined significance (MGUS) patients. Haematologica 2009; June 22 [E-pub ahead of print].","DOI":"10.3324\/haematol.2009.006346"},{"key":"BFleu2009134_CR39","first-page":"177","volume":"1","author":"LM Pottern","year":"1992","unstructured":"Pottern LM, Gart JJ, Nam JM, Dunston G, Wilson J, Greenberg R et al. HLA and multiple myeloma among black and white men: evidence of a genetic association. Cancer Epidemiol Biomarkers Prev 1992; 1: 177\u2013182.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFleu2009134_CR40","unstructured":"Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. SEER Cancer Statistics Review, 1975\u20132005, National Cancer Institute http:\/\/seer.cancer.gov\/csr\/1975_2005\/ 2008, [cited March 17, 2009]; Available from: http:\/\/seer.cancer.gov\/csr\/1975_2005\/."},{"key":"BFleu2009134_CR41","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3","volume":"82","author":"FD Groves","year":"1998","unstructured":"Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni Jr JF . Waldenstrom's macroglobulinemia: incidence patterns in the United States, 1988\u20131994. Cancer 1998; 82: 1078\u20131081.","journal-title":"Cancer"},{"key":"BFleu2009134_CR42","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V82.10.3148.3148","volume":"82","author":"LJ Herrinton","year":"1993","unstructured":"Herrinton LJ, Weiss NS . Incidence of Waldenstrom's macroglobulinemia. Blood 1993; 82: 3148\u20133150.","journal-title":"Blood"},{"key":"BFleu2009134_CR43","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1023\/A:1018498414298","volume":"8","author":"LM Brown","year":"1997","unstructured":"Brown LM, Pottern LM, Silverman DT, Schoenberg JB, Schwartz AG, Greenberg RS et al. Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beverages. Cancer Causes Control 1997; 8: 610\u2013614.","journal-title":"Cancer Causes Control"},{"key":"BFleu2009134_CR44","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","volume":"111","author":"LM Brown","year":"2008","unstructured":"Brown LM, Gridley G, Check D, Landgren O . Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388\u20133394.","journal-title":"Blood"},{"key":"BFleu2009134_CR45","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S et al. The molecular classification of multiple myeloma. Blood 2006; 108: 2020\u20132028.","journal-title":"Blood"},{"key":"BFleu2009134_CR46","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","volume":"26","author":"O Decaux","year":"2008","unstructured":"Decaux O, Lode L, Magrangeas F, Charbonnel C, Gouraud W, Jezequel P et al. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myelome. J Clin Oncol 2008; 26: 4798\u20134805.","journal-title":"J Clin Oncol"},{"key":"BFleu2009134_CR47","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","volume":"109","author":"H Avet-Loiseau","year":"2007","unstructured":"Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 2007; 109: 3489\u20133495.","journal-title":"Blood"},{"key":"BFleu2009134_CR48","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1200\/JCO.1996.14.3.974","volume":"14","author":"MR Modiano","year":"1996","unstructured":"Modiano MR, Villar-Werstler P, Crowley J, Salmon SE . Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. J Clin Oncol 1996; 14: 974\u2013977.","journal-title":"J Clin Oncol"},{"key":"BFleu2009134_CR49","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.bmt.1705392","volume":"37","author":"S Saraf","year":"2006","unstructured":"Saraf S, Chen YH, Dobogai LC, Mahmud N, Peace D, Saunthararajah Y et al. Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma. Bone Marrow Transplant 2006; 37: 1099\u20131102.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2009134_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ajh.21139","volume":"83","author":"PS Verma","year":"2008","unstructured":"Verma PS, Howard RS, Weiss BM . The impact of race on outcomes of autologous transplantation in patients with multiple myeloma. Am J Hematol 2008; 83: 355\u2013358.","journal-title":"Am J Hematol"},{"key":"BFleu2009134_CR51","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMe058265","volume":"354","author":"N Risch","year":"2006","unstructured":"Risch N . Dissecting racial and ethnic differences. N Engl J Med 2006; 354: 408\u2013411.","journal-title":"N Engl J Med"},{"key":"BFleu2009134_CR52","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrg1657","volume":"6","author":"MW Smith","year":"2005","unstructured":"Smith MW, O'Brien SJ . Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet 2005; 6: 623\u2013632.","journal-title":"Nat Rev Genet"},{"key":"BFleu2009134_CR53","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1086\/513206","volume":"80","author":"D Reich","year":"2007","unstructured":"Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet 2007; 80: 716\u2013726.","journal-title":"Am J Hum Genet"},{"key":"BFleu2009134_CR54","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1182\/blood-2004-01-0037","volume":"104","author":"T Hideshima","year":"2004","unstructured":"Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC . Advances in biology of multiple myeloma: clinical applications. Blood 2004; 104: 607\u2013618.","journal-title":"Blood"},{"key":"BFleu2009134_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb01584.x","volume":"48","author":"F Aguzzi","year":"1992","unstructured":"Aguzzi F, Bergami MR, Gasparro C, Bellotti V, Merlini G . Occurrence of monoclonal components in general practice: clinical implications. Eur J Haematol 1992; 48: 192\u2013195.","journal-title":"Eur J Haematol"},{"key":"BFleu2009134_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/jcp.35.1.63","volume":"35","author":"JP Saleun","year":"1982","unstructured":"Saleun JP, Vicariot M, Deroff P, Morin JF . Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol 1982; 35: 63\u201368.","journal-title":"J Clin Pathol"},{"key":"BFleu2009134_CR57","first-page":"157","volume":"17","author":"AO Vladutiu","year":"1987","unstructured":"Vladutiu AO . Prevalence of M-proteins in serum of hospitalized patients. Physicians' response to finding M-proteins in serum protein electrophoresis. Ann Clin Lab Sci 1987; 17: 157\u2013161.","journal-title":"Ann Clin Lab Sci"},{"key":"BFleu2009134_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","volume":"179","author":"U Axelsson","year":"1966","unstructured":"Axelsson U, Bachmann R, Hallen J . Frequency of pathological proteins (M-components) on 6995 sera from an adult population. Acta Med Scand 1966; 179: 235\u2013247.","journal-title":"Acta Med Scand"},{"key":"BFleu2009134_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1445-5994.1971.tb02551.x","volume":"1","author":"RW Carrell","year":"1971","unstructured":"Carrell RW, Colls BM, Murray JT . The significance of monoclonal gammopathy in a normal population. Aust N Z J Med 1971; 1: 398\u2013401.","journal-title":"Aust N Z J Med"},{"key":"BFleu2009134_CR60","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1136\/jcp.40.7.793","volume":"40","author":"V Malacrida","year":"1987","unstructured":"Malacrida V, De Francesco D, Banfi G, Porta FA, Riches PG . Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital. J Clin Pathol 1987; 40: 793\u2013797.","journal-title":"J Clin Pathol"},{"key":"BFleu2009134_CR61","volume-title":"Cancer Incidence in Five Continents","author":"MP Curado","year":"2007","unstructured":"Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M et al. Cancer Incidence in Five Continents, Vol IX, IARC Scientific Publications No. 160 IARC: Lyon, 2007."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009134","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:09:48Z","timestamp":1648714188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,9]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFleu2009134"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.134","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,9]]},"assertion":[{"value":"17 March 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}